ALPHA COGNITION INC(ACOG)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ACOG ALPHA COGNITION INC

交易中 08-14 10:47:02 EDT

8.86

+0.23

+2.61%

最高9.50	最低8.25	成交量11.10万
今开9.29	昨收8.63	日振幅14.54%
总市值1.93亿	流通市值1.33亿	总股本2,174万
成交额100.22万	换手率0.74%	流通股本1,506万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ACOG","market":"US","secType":"STK","nameCN":"ALPHA COGNITION INC","latestPrice":8.855,"timestamp":1786718809406,"preClose":8.63,"halted":0,"volume":110958,"delay":0,"changeRate":0.026071842410196944,"floatShares":15056000,"shares":21742100,"eps":-1.365387,"marketStatus":"交易中","change":0.225,"latestTime":"08-14 10:47:02 EDT","open":9.29,"high":9.5,"low":8.245,"amount":1002163.8903180001,"amplitude":0.145423,"askPrice":8.95,"askSize":25,"bidPrice":8.8,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.365387,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1786737600000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":8.63,"preHourTrading":{"tag":"盘前","latestPrice":9.34,"preClose":8.63,"latestTime":"09:29 EDT","volume":3722,"amount":36099.32441,"timestamp":1786714199999,"change":0.71,"changeRate":0.082271,"amplitude":0.079954},"postHourTrading":{"tag":"盘后","latestPrice":9.7499,"preClose":8.63,"latestTime":"19:51 EDT","volume":17265,"amount":157855.733,"timestamp":1786665081283,"change":1.1199,"changeRate":0.129768,"amplitude":0.152955},"volumeRatio":6.846504,"impliedVol":0.5282,"impliedVolPercentile":0.5},"requestUrl":"/m/hq/s/ACOG/wiki","defaultTab":"wiki","newsList":[{"id":"1150085578","title":"Alpha Cognition宣布首位患者入组评估Zunveyl®用于轻中度阿尔茨海默病的Resolve第四期研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1150085578","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1150085578?lang=zh_cn&edition=full","pubTime":"2026-06-16 20:30","pubTimestamp":1781613054,"startTime":"0","endTime":"0","summary":"Alpha Cognition Inc.宣布，其Resolve第四期研究已迎来首位患者入组。这项研究旨在评估Zunveyl®在轻至中度阿尔茨海默病患者中的疗效与安全性。该里程碑标志着公司在该药物临床开发进程中的关键一步，为后续数据收集与分析奠定了基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACOG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181886473","title":"Alpha Cognition：八成Zunveyl患者精神药物使用出现延迟或中断","url":"https://stock-news.laohu8.com/highlight/detail?id=1181886473","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1181886473?lang=zh_cn&edition=full","pubTime":"2026-06-09 20:01","pubTimestamp":1781006473,"startTime":"0","endTime":"0","summary":"根据医疗服务提供者的报告，在使用Zunveyl的患者中，高达80%的人其精神类药物的使用出现了延迟或中断的情况。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACOG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124277263","title":"Alpha Cognition公布Zunveyl®治疗阿尔茨海默病Beacon真实世界研究积极顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1124277263","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124277263?lang=zh_cn&edition=full","pubTime":"2026-06-09 20:00","pubTimestamp":1781006423,"startTime":"0","endTime":"0","summary":"ALPHA COGNITION INC宣布，其Zunveyl®用于治疗阿尔茨海默病的Beacon真实世界研究取得了积极的顶线结果。这一进展为该公司在该领域的研发提供了重要的临床数据支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACOG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153779206","title":"Alpha Cognition（纳斯达克：ACOG）将于2026年5月14日周四公布2026年第一季度财报并举行业务进展说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=1153779206","media":"美股速递","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1153779206?lang=zh_cn&edition=full","pubTime":"2026-04-29 04:32","pubTimestamp":1777408355,"startTime":"0","endTime":"0","summary":"Alpha Cognition Inc（纳斯达克股票代码：ACOG）计划于2026年5月14日星期四发布其2026年第一季度的财务业绩报告。届时，公司管理层还将同步召开业务进展说明会，向投资者和市场参与者详细介绍公司的最新运营动态与发展规划。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACOG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197935470","title":"Alpha Cognition Inc达成和解协议 和解金额较债务预估市值折让约40%","url":"https://stock-news.laohu8.com/highlight/detail?id=1197935470","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1197935470?lang=zh_cn&edition=full","pubTime":"2026-04-15 04:03","pubTimestamp":1776197011,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会最新文件披露，Alpha Cognition Inc已与相关方达成债务和解协议。值得关注的是，此次和解金额较债务的预估市场价值存在约40%的折让幅度。\n这一折让比例反映出公司在债务重组谈判中取得了显著优势。通过以低于市场估值的价格清偿债务，Alpha Cognition Inc将有效改善其资产负债表结构，为后续业务发展创造更有利的财务环境。\n市场分析人士指出，此类债务和解安排通常意味着公司正积极优化资本结构，可能预示着未来战略调整或业务重组计划。折让幅度的大小往往体现了债权人对公司偿债能力的评估结果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACOG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100733416","title":"Alpha Cognition Inc与Galantos Pharma于2026年4月10日达成和解协议 - 美国证券交易委员会文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1100733416","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100733416?lang=zh_cn&edition=full","pubTime":"2026-04-15 04:03","pubTimestamp":1776196996,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会（SEC）最新披露的文件，Alpha Cognition Inc（股票代码：ACOG）已于2026年4月10日与Galantos Pharma正式签署一项和解协议。该协议的达成标志着双方此前存在的争议或法律纠纷已通过协商方式得到解决。\n具体协议条款及涉及金额等细节未在公开文件中详尽披露，但此次和解预计将为Alpha Cognition Inc未来的业务运营和战略发展消除不确定性。市场关注此举是否会对公司财务状况及股价表现产生积极影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACOG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176394808","title":"Alpha Cognition（纳斯达克：ACOG）将于2026年3月26日周四公布2025年第四季度及全年财务业绩并举行业务更新会","url":"https://stock-news.laohu8.com/highlight/detail?id=1176394808","media":"美股速递","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176394808?lang=zh_cn&edition=full","pubTime":"2026-03-14 01:47","pubTimestamp":1773424031,"startTime":"0","endTime":"0","summary":"ALPHA COGNITION INC（纳斯达克股票代码：ACOG）宣布，公司计划于2026年3月26日，星期四，发布其2025年第四季度以及全年的财务业绩报告。\n此次发布将详细披露公司在指定期间内的财务表现。同时，管理层将举行业务更新会议，向投资者和市场参与者介绍公司的最新运营进展、战略规划及未来展望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACOG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616075589","title":"Alpha Cognition Inc.盘中异动 早盘股价大跌5.00%报5.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616075589","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2616075589?lang=zh_cn&edition=full","pubTime":"2026-03-03 22:58","pubTimestamp":1772549901,"startTime":"0","endTime":"0","summary":"北京时间2026年03月03日22时58分，Alpha Cognition Inc.股票出现异动，股价大幅下挫5.00%。截至发稿，该股报5.51美元/股，成交量1442股，换手率0.01%，振幅0.00%。Alpha Cognition Inc.股票所在的生物技术行业中，整体跌幅为1.56%。Alpha Cognition Inc.公司简介：Alpha Cognition Inc是一家商业阶段的生物制药公司，致力于为患有神经退行性疾病的患者开发治疗方法，如阿尔茨海默病，这些疾病的治疗选择有限甚至没有。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603032258219542d53c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603032258219542d53c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACOGD","BK4139","ACOGF","ACOG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613273463","title":"Alpha Cognition Inc.盘中异动 早盘快速跳水6.32%报5.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2613273463","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2613273463?lang=zh_cn&edition=full","pubTime":"2026-02-24 00:00","pubTimestamp":1771862408,"startTime":"0","endTime":"0","summary":"北京时间2026年02月24日00时00分，Alpha Cognition Inc.股票出现异动，股价快速下挫6.32%。截至发稿，该股报5.48美元/股，成交量1.2184万股，换手率0.06%，振幅4.70%。Alpha Cognition Inc.股票所在的生物技术行业中，整体涨幅为0.11%。Alpha Cognition Inc.公司简介：Alpha Cognition Inc是一家商业阶段的生物制药公司，致力于为患有神经退行性疾病的患者开发治疗方法，如阿尔茨海默病，这些疾病的治疗选择有限甚至没有。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224000008a4bf7ab5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224000008a4bf7ab5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACOGD","ACOG","ACOGF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2485200544","title":"Alpha Cognition Inc.2024财年第三财季实现净利润-1.86百万美元，同比增加43.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485200544","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2485200544?lang=zh_cn&edition=full","pubTime":"2024-11-24 00:00","pubTimestamp":1732377620,"startTime":"0","endTime":"0","summary":"11月24日，Alpha Cognition Inc.公布财报，公告显示公司2024财年第三财季净利润为-1.86百万美元，同比增加43.98%；其中营业收入为0.00美元，每股基本收益为-0.31美元。从资产负债表来看，Alpha Cognition Inc.总负债7.95百万美元，其中短期债务1.21百万美元，资产负债比为0.64，流动比率为1.50。机构评级：截至2024年11月24日，当前有1家机构对Alpha Cognition Inc.目标价做出预测，其中目标均价为36.13美元，其中最低目标价为36.13美元，最高目标价为36.13美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241124000028abd9b88e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241124000028abd9b88e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACOG","ACOGD","ACOGF"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alphacognition.com","stockEarnings":[{"period":"1week","weight":-0.0046},{"period":"1month","weight":0.072},{"period":"3month","weight":0.4336},{"period":"6month","weight":0.7684},{"period":"1year","weight":-0.1361},{"period":"ytd","weight":0.3277}],"compareEarnings":[{"period":"1week","weight":0.0121},{"period":"1month","weight":0.0346},{"period":"3month","weight":0.0524},{"period":"6month","weight":0.141},{"period":"1year","weight":0.2062},{"period":"ytd","weight":0.1407}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Alpha Cognition Inc.于2017年11月15日根据《不列颠哥伦比亚省商业公司法》（“BCBCA”）成立，名称为“Crystal Bridge Enterprises Inc.”，为加拿大资本联营公司。他们于2021年3月18日完成了与Alpha Cognition Canada Inc.的合格交易，并将其名称更改为Alpha Cogning股份有限公司。Alpha Cognition, Inc.是一家商业化前阶段的生物制药公司，致力于为阿尔茨海默病等神经退行性疾病患者开发治疗方法。","exchange":"NASDAQ","name":"ALPHA COGNITION INC","nameEN":"ALPHA COGNITION INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ALPHA COGNITION INC(ACOG)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ALPHA COGNITION INC(ACOG)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ALPHA COGNITION INC,ACOG,ALPHA COGNITION INC股票,ALPHA COGNITION INC股票老虎,ALPHA COGNITION INC股票老虎国际,ALPHA COGNITION INC行情,ALPHA COGNITION INC股票行情,ALPHA COGNITION INC股价,ALPHA COGNITION INC股市,ALPHA COGNITION INC股票价格,ALPHA COGNITION INC股票交易,ALPHA COGNITION INC股票购买,ALPHA COGNITION INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ALPHA COGNITION INC(ACOG)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ALPHA COGNITION INC(ACOG)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}